GNPX
Income statement / Annual
Last year (2025), Genprex Inc's total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2025, Genprex Inc's net income was -$16.23 M.
See Genprex Inc,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
12/31/2025 |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
| Operating Revenue |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Cost of Revenue |
$0.00
|
$6.69 K
|
$15.00 K
|
$25.58 K
|
$22.53 K
|
$22.78 K
|
$13.07 K
|
$5.89 K
|
$0.00
|
$0.00
|
| Gross Profit |
$0.00
|
-$6.69 K
|
-$15.00 K
|
-$25.58 K
|
-$22.53 K
|
-$22.78 K
|
-$13.07 K
|
-$5.89 K
|
$0.00
|
$0.00
|
| Gross Profit Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Research and Development Expenses |
$9.43 M
|
$10.54 M
|
$17.62 M
|
$11.51 M
|
$8.97 M
|
$7.30 M
|
$1.97 M
|
$971.43 K
|
$289.93 K
|
$354.88 K
|
| General & Administrative Expenses |
$6.09 M
|
$0.00
|
$13.44 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$11.39 M
|
$3.02 M
|
$3.78 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$6.09 M
|
$10.63 M
|
$13.44 M
|
$12.30 M
|
$11.68 M
|
$10.64 M
|
$8.70 M
|
$11.39 M
|
$3.02 M
|
$3.78 M
|
| Other Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$5.89 K
|
$3.24 K
|
$0.00
|
| Operating Expenses |
$15.52 M
|
$21.17 M
|
$31.06 M
|
$23.81 M
|
$20.65 M
|
$17.94 M
|
$10.67 M
|
$12.36 M
|
$3.31 M
|
$4.13 M
|
| Cost And Expenses |
$15.52 M
|
$21.17 M
|
$31.08 M
|
$23.83 M
|
$20.67 M
|
$17.96 M
|
$10.68 M
|
$12.36 M
|
$3.31 M
|
$4.13 M
|
| Interest Income |
$0.00
|
$63.57 K
|
$215.11 K
|
$90.10 K
|
$5.13 K
|
$18.81 K
|
$27.91 K
|
$29.18 K
|
$80.00
|
$0.00
|
| Interest Expense |
$739.94 K
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$37.98 K
|
$1.89 K
|
$0.00
|
| Depreciation & Amortization |
$0.00
|
$6.69 K
|
$15.00 K
|
$25.58 K
|
$22.53 K
|
$22.78 K
|
$13.07 K
|
$5.89 K
|
$3.24 K
|
$862.00
|
| EBITDA |
-$15.49 M |
-$21.10 M |
-$31.06 M |
-$23.72 M |
-$20.64 M |
-$17.92 M |
-$10.64 M |
-$12.33 M |
-$3.31 M |
-$4.13 M |
| EBITDA Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Operating Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other Income/Expenses Net |
-$713.33 K
|
$63.00 K
|
$215.11 K
|
$90.10 K
|
$5.13 K
|
$18.81 K
|
$27.91 K
|
-$8.80 K
|
-$1.81 K
|
$0.00
|
| Income Before Tax |
-$16.23 M
|
-$21.11 M
|
-$30.86 M
|
-$23.74 M
|
-$20.66 M
|
-$17.94 M
|
-$10.65 M
|
-$12.37 M
|
-$3.31 M
|
-$4.13 M
|
| Income Before Tax Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$29.18 K
|
$80.00
|
$0.00
|
| Net Income |
-$16.23 M
|
-$21.11 M
|
-$30.86 M
|
-$23.74 M
|
-$20.66 M
|
-$17.94 M
|
-$10.65 M
|
-$12.37 M
|
-$3.31 M
|
-$4.13 M
|
| Net Income Ratio |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| EPS |
-17.4 |
-266.9535 |
-1129 |
-990 |
-877.5 |
-1009 |
-1332 |
-1798.5 |
-577.5 |
-765 |
| EPS Diluted |
-17.4 |
-266.9535 |
-1128 |
-990 |
-877.5 |
-1009 |
-1329.5 |
-1797 |
-576.5 |
-763 |
| Weighted Average Shares Out |
$932.73 K
|
$80.12 K
|
$27.34 K
|
$23.96 K
|
$23.54 K
|
$17.76 K
|
$8.00 K
|
$6.88 K
|
$5.74 K
|
$5.40 K
|
| Weighted Average Shares Out Diluted |
$932.73 K
|
$80.12 K
|
$27.36 K
|
$23.98 K
|
$23.55 K
|
$17.76 K
|
$8.01 K
|
$6.89 K
|
$5.75 K
|
$5.42 K
|
| Link |
|
|
|
|
|
|
|
|
|
|
